Endeavor BioMedicines

Private

#Pulmonary Fibrosis #Oncology #Fibrotic Diseases

Clinical-stage biotech in Solana Beach, CA developing precision therapeutics for oncology and fibrotic diseases. Raised $132.5M in Series C.

Company Info

Sector:Small Molecule Pharma

Headquarters:Solana Beach, California, USA

Founded:2019

Website:endeavorbiomedicines.com/

Upcoming Milestones & Key Dates

2026-09

Conference

ERS Congress IPF Phase 2a results presentation

2026-Q4

Clinical

ENV-101 IPF Phase 2a data readout

Clinical Development Pipeline

ENV-101

Target: TEAD inhibitor

Idiopathic Pulmonary Fibrosis

Preclinical

Phase 1

Phase 2

Phase 3

Approved

ENV-101

Target: TEAD inhibitor

Oncology

Preclinical

Phase 1

Phase 2

Phase 3

Approved

ENV-201

Target: Undisclosed

Fibrotic Diseases

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

No recent news updates available for this company.

Leadership Team

Paul Bhatt

CEO

Katherine Bowdish

Chief Scientific Officer

David Bhatt

Chief Medical Officer

Careers & Job Openings

See all open roles

Various

Solana Beach, CA

Apply Now →